Interstitial Pneumonia from Mitomycin
作者： ERIC S ORWOLL , PETER J KIESSLING , JAMES R PATTERSON
DOI: 10.7326/0003-4819-89-3-352
关键词:
摘要: Abstract Pulmonary disease has been associated with several chemotherapeutic agents but not reported in patients receiving the alkylating agent mitomycin (Mutamycin®). We describe here the...
elsevier.com
sci-hub.se 参考文章(23)
Halsted R. Holman, James F. Fries, Systemic lupus erythematosus: A clinical analysis ,(1975)
Herbert S. Schwartz, Stephen S. Sternberg, Frederick S. Philips, Pharmacology of mitomycin C. I. Toxicity and pathologic effects. Cancer Research. ,vol. 20, pp. 1354- 1361 ,(1960)
Herman Oliner, Robert Schwartz, Fernando Rubio, William Dameshek, Interstitial pulmonary fibrosis following busulfan therapy The American Journal of Medicine. ,vol. 31, pp. 134- 139 ,(1961) , 10.1016/0002-9343(61)90229-7
PHILIP S. SCHEIN, Immunosuppressive and Cytotoxic Chemotherapy: Long-Term Complications Annals of Internal Medicine. ,vol. 82, pp. 84- 95 ,(1975) , 10.7326/0003-4819-82-1-84
Gilbert J. Hum, Donald L. Bogdon, Joseph R. Bateman, Phase I-II evaluation of weekly mitomycin-C (NSC-26980) for patients with metastatic GI and breast malignancies. Oncology. ,vol. 30, pp. 236- 243 ,(1974) , 10.1159/000224961
Averill A. Liebow, Arthur Steer, James G. Billingsley, Desquamative interstitial pneumonia The American Journal of Medicine. ,vol. 39, pp. 369- 404 ,(1965) , 10.1016/0002-9343(65)90206-8
Thomas E. Godfrey, David W. Wilbur, Clinical experience with mitomycin C in large infrequent doses. Cancer. ,vol. 29, pp. 1647- 1652 ,(1972) , 10.1002/1097-0142(197206)29:6<1647::AID-CNCR2820290632>3.0.CO;2-6
ARNOLD S. BAYER, Dilantin® Toxicity: Miliary Pulmonary Infiltrates and Hypoxemia Annals of Internal Medicine. ,vol. 85, pp. 475- 476 ,(1976) , 10.7326/0003-4819-85-4-475
H DIRK SOSTMAN, RICHARD A. MATTHAY, CHARLES E. PUTMAN, G J WALKER SMITH, Methotrexate-induced pneumonitis. Medicine. ,vol. 55, pp. 371- 388 ,(1976) , 10.1097/00005792-197609000-00002
STANLEY L. LEE, Activation of Systemic Lupus Erythematosus by Drugs JAMA Internal Medicine. ,vol. 117, pp. 620- 626 ,(1966) , 10.1001/ARCHINTE.1966.03870110012003